发明名称 Neue 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
摘要 1-(1-(Hetero)aryl)-1-(polyhydroxyalkyl)-methyl)-4-(4-(N-methylbenzamid o)-3-phenylbutyl)-piperazine derivatives (I) are new. Also new are 1-unsubstituted analog intermediates (II). 1-(1-(Hetero)aryl)-1-(polyhydroxyalkyl)-methyl)-4-(4-(N-methylbenzamid o)-3-phenylbutyl)-piperazine derivatives of formula (I) and their acid addition salts are new. A = naphthyl, phenyl (optionally substituted by OH), mono- or bi-cyclic heteroaryl or 3-6C alkenyl (optionally substituted by phenyl); Q = (CHOR1)k-(CHOR2)l-(CHOR3)m-(CHOR4)n-CH2OR5 ; R1-R5 = H or lower alkanoyl, or two of R1-R5 = CO, CS or CH2 (optionally substituted by lower alkyl or 4-5C alkylene), completing a 5- or 6-membered ring; k, l, m, n = 0 or 1, and R6, R7 = H or halo. Independent claims are also included for: (1) the preparation of (I), and (2) new piperazine derivative intermediates of formula (II).
申请公布号 DE50204379(D1) 申请公布日期 2006.02.09
申请号 DE2002504379 申请日期 2002.09.07
申请人 SOLVAY PHARMACEUTICALS GMBH 发明人 JASSERAND, DANIEL;PREUSCHOFF, ULF;ANTEL, JOCHEN;DAVID, SAMUEL;SANN, HOLGER;BRUECKNER, REINHARD;REICHE, DANIA;EECKHOUT, CHRISTIAN
分类号 C07D295/12;A61K31/341;A61K31/381;A61K31/496;A61P1/00;A61P29/00;A61P43/00;C07D209/08;C07D295/08;C07D295/084;C07D295/092;C07D307/52;C07D333/20;C07D407/04;C07D407/06;C07D409/06 主分类号 C07D295/12
代理机构 代理人
主权项
地址